Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Celldex (CLDX) Ownership Overview
0.36% Insiders
28.51% Mutual Funds
47.05% Other Institutional Investors
14.37% ETFs
9.72% Public Companies and
Individual Investors
The ownership structure of Celldex (CLDX) stock is a mix of institutional, retail, and individual investors. Approximately 89.93% of the company’s stock is owned by Institutional Investors, 0.36% is owned by Insiders, and 9.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 08, 2025 | xxxxxxxxxxxxx | $121189 | |
Nov 17, 2025 | xxxxxxxxxxxxx | $1183152 | |
Aug 15, 2025 | xxxxxxxxxxxxx | $10926 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $13583449 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $25453211 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,694,348 | Institution | 5.55% | 110,941,270 | |
| 3,412,743 | Institution | 5.13% | 102,484,672 | |
| 2,825,941 | Institution | 4.25% | 84,863,008 | |
| 2,479,261 | Institution | 3.72% | 74,452,208 | |
| 2,078,154 | Institution | 3.12% | 62,406,965 | |
| 1,666,317 | Institution | 2.50% | 50,039,500 | |
| 1,567,068 | Institution | 2.35% | 47,059,052 | |
| 1,108,774 | Institution | 1.67% | 33,296,483 | |
| 1,057,540 | Institution | 1.59% | 31,757,926 | |
| 937,158 | Institution | 1.41% | 28,142,855 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,694,348 | Institution | 5.55% | 110,941,270 | |
| 2,825,941 | Institution | 4.25% | 84,863,008 | |
| 1,666,317 | Institution | 2.50% | 50,039,500 | |
| 1,567,068 | Institution | 2.35% | 47,059,052 | |
| 1,108,774 | Institution | 1.67% | 33,296,483 | |
| 1,057,540 | Institution | 1.59% | 31,757,926 | |
| 742,282 | Institution | 1.12% | 22,290,728 | |
| 563,399 | Institution | 0.85% | 16,918,872 | |
| 558,969 | Institution | 0.84% | 16,785,839 | |
| 538,361 | Institution | 0.81% | 16,166,981 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,128,878 | Institution | 3.20% | 64,057,939 | |
| 1,943,876 | Institution | 2.92% | 55,478,221 | |
| 1,609,496 | Institution | 2.42% | 48,333,165 | |
| 725,971 | Institution | 1.09% | 21,844,467 | |
| 567,402 | Institution | 0.85% | 17,039,082 | |
| 324,506 | Institution | 0.49% | 9,764,386 | |
| 322,375 | Institution | 0.48% | 9,200,583 | |
| 203,792 | Institution | 0.31% | 5,816,224 | |
| 179,933 | Institution | 0.27% | 5,414,184 | |
| 119,834 | Institution | 0.18% | 3,598,615 |
FAQ
Who Owns Celldex Therapeutics Inc (CLDX)?
According to the latest TipRanks data, approximately 47.05% of the company's stock is held by institutional investors, 0.36% is held by insiders, and 9.72% is held by retail investors.
What percentage of Celldex Therapeutics Inc (CLDX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.05% of Celldex Therapeutics Inc (CLDX) stock is held by institutional investors.
What percentage of Celldex Therapeutics Inc (CLDX) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.72% of Celldex Therapeutics Inc (CLDX) stock is held by retail investors.
Who owns the most shares of Celldex Therapeutics Inc (CLDX)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Celldex Therapeutics Inc (CLDX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.